USPTO 2015–2025 USPTO PatentsView US Corporation

Dcb-usa LLC

USPTO PatentsView assignee record - 9 granted patents across 7 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Dcb-usa ranks #28,543 of 49,997 tracked US assignees by granted-patent volume, with 9 patents across 7 technology areas.

#28,543
of 49,997 US assignees by volume
15th percentile
by Innovation Score (24.5/100)
12.0
avg claims per patent
-50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R28543 · US Corporation #28,543 · 9 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 9 grants
  • MID-PACK #28,543/49,997
  • PHOTO-FINISH Dairymaster
  • CPC-NARROW A61P · 7 areas
  • INNOV-THIN 24.5/100
  • CLAIMS-RICH 12.0 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -50% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dairymaster (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Dcb-usa’s 24.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Dcb-usa

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Dcb-usa's Innovation Score is 24.5/100 (15th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Dcb-usa?

Each dot is one of Dcb-usa’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Dcb-usa’s own 12.0 claims/patent is at or below the 13.9 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Dcb-usa vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 8.98.999.1 10152025 Granted patents (volume) Avg claims / patent Dairymaster - 9, 21.56DairymasterDAP Products, Inc. - 9, 19.11DAP ProductsDatt Life Sciences Private Limited - 9, 13.33Datt Life Science…Davinci Lock LLC - 9, 15.89Davinci LockDE Poan Pneumatic Corp. - 9, 12.44DE Poan PneumaticDe-sta-co Europe GmbH - 9, 11.22De-sta- EuropeDeckel Maho Seebach GMBH - 9, 18Deckel Maho Seeba…Deep BIO Inc. - 9, 13.89Deep BIODcb-usa LLC - 9, 12Dcb-usa
Dcb-usa vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Dcb-usa's grants concentrate

Dcb-usa LLC is a focused PatentsView assignee: 7 CPC subclasses with 66.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (3 grants) versus a trough of 1 in 2020. By volume, Dcb-usa sits between Dairymaster and Deep BIO Inc..

Who files at Dcb-usa's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Dcb-usa holds 9 patents at rank #28,528, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Dcb-usa

By rank, the assignees closest to #28,528 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Dcb-usa's primary technology class.

Dcb-usa's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 15th percentile higher than 15% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 2015201620202021 2
USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Dcb-usa LLC patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 3 33.3%
2016 3 33.3%
2020 1 11.1%
2021 2 22.2%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Dcb-usa LLC's patent record in context - here's where to go next.

  • Dcb-usa LLC's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 66.7% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #28,543 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Dcb-usa LLC against Dairymaster, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 24.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.